 |
|
Journal articles
Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment
Abstract : Significant peripheral blood CD4+ T-cell depletion has been observed after a first cycle of rituximab, a monoclonal antibody directed against the CD20 antigen, which is currently used in rheumatoid arthritis. Of note, an absence of CD4+ T-cell decrease has been observed in non-responders. Herein, we describe CD4+ T-cell changes over repeated cycles of rituximab and their relationship with clinical outcomes.
Cited literature [15 references]
https://hal-univ-tours.archives-ouvertes.fr/hal-01403387
Contributor : Denis Mulleman <>
Submitted on : Friday, November 25, 2016 - 7:40:55 PM
Last modification on : Wednesday, December 4, 2019 - 2:38:02 PM
Document(s) archivé(s) le : Tuesday, March 21, 2017 - 4:15:19 AM
Contributor : Denis Mulleman <>
Submitted on : Friday, November 25, 2016 - 7:40:55 PM
Last modification on : Wednesday, December 4, 2019 - 2:38:02 PM
Document(s) archivé(s) le : Tuesday, March 21, 2017 - 4:15:19 AM
File
Lavielle ART 2016.pdf
Publisher files allowed on an open archive
